# EXTEND-OP (NCT06367972)

> A Randomized Phase II Basket Trial EXTENDing Efficacy of Systemic Therapy With Local Consolidative Therapy for OligoProgressive Metastatic Disease (EXTEND-OP)

No report yet. It can be ordered.

## Registry

- Registry record: https://clinicaltrials.gov/study/NCT06367972
- Phase: PHASE2, PHASE3
- Status: RECRUITING
- Sponsor: M.D. Anderson Cancer Center
- Conditions: OligoProgressive Metastatic Disease
- Interventions: Local Consolidation Therapy; Next-line Systemic Therapy
- Enrollment: 400
- Primary outcome: Safety and adverse events (AEs)

## Indexed commentary on EXTEND-OP so far

Podcasts, YouTube videos and X posts we have indexed that name the trial. This is where a report starts, not where it ends: the build searches for more, so finished reports usually cover more than this.

- X threads: 13
- YouTube: 3
- Podcasts: 1
- Bluesky threads: 1

## Order

Standard, $1,250, price fixed at order: https://www.erudio.com/contact?report=extend-op-nct06367972

## Free preview

POST https://www.erudio.com/api/trial-requests with {"nct_id": "NCT06367972", "email": "<work email>"}; the inbox owner confirms by the emailed link.